Recombinant human tumor necrosis factor α does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells

  • Authors:
    • Kashif Azizuddin
    • Katrin Kalka
    • Song-Mao Chiu
    • Nihal Ahmad
    • Hasan Mukhtar
    • Duska Separovic
  • View Affiliations

  • Published online on: February 1, 2001     https://doi.org/10.3892/ijo.18.2.411
  • Pages: 411-415
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Photodynamic therapy (PDT) is a novel cancer treatment utilizing a photosensitizer, visible light and oxygen. PDT with the silicon phthalocyanine Pc 4, a new photosensitizer, is highly effective in cancer cell destruction and tumor ablation. The mechanisms underlying cancer cell killing by PDT are not fully understood. Tumor necrosis factor α (TNF) is a multifunctional cytokine that has been implicated in photocytotoxicity. We asked whether recombinant human TNF (rhTNF) affects Pc 4-PDT cytotoxicity in A431 human epidermoid carcinoma cells. Co-treatment of A431 cells with various doses of Pc 4-PDT and a sub-lethal rhTNF dose led to a sub-additive reduction in cell survival. In addition, in the presence of Pc 4-PDT or rhTNF, caspase-3 activity and apoptosis were induced. The combined treatment, however, did not potentiate either caspase-3 activity or apoptosis. Similar to previous findings we observed that Pc 4-PDT initiated a time-dependent extracellular TNF accumulation. The data suggest that: a) PDT and rhTNF induce cancer cell killing through different mechanisms; and b) Pc 4-PDT-induced TNF production is a stress response that may not directly affect photocytotoxicity.

Related Articles

Journal Cover

February 2001
Volume 18 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Azizuddin K, Kalka K, Chiu S, Ahmad N, Mukhtar H and Separovic D: Recombinant human tumor necrosis factor α does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells. Int J Oncol 18: 411-415, 2001.
APA
Azizuddin, K., Kalka, K., Chiu, S., Ahmad, N., Mukhtar, H., & Separovic, D. (2001). Recombinant human tumor necrosis factor α does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells. International Journal of Oncology, 18, 411-415. https://doi.org/10.3892/ijo.18.2.411
MLA
Azizuddin, K., Kalka, K., Chiu, S., Ahmad, N., Mukhtar, H., Separovic, D."Recombinant human tumor necrosis factor α does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells". International Journal of Oncology 18.2 (2001): 411-415.
Chicago
Azizuddin, K., Kalka, K., Chiu, S., Ahmad, N., Mukhtar, H., Separovic, D."Recombinant human tumor necrosis factor α does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells". International Journal of Oncology 18, no. 2 (2001): 411-415. https://doi.org/10.3892/ijo.18.2.411